Pathogenetic mechanisms of genetic diseases
The genetic material controls life activities of the cell through regulating the synthesis of proteins which directly mediate these activities. Regulatory genes, in addition, control the transcription of many classes of small RNAs that have fundamental roles in direct and feed-back regulation of most aspects of the genetic material [1] .
Mutations cause structural alterations of the genetic material. Depending on the site, nature, magnitude and effects of the mutational event as well as on the functions and importance of the mutated genes, pathogenetic mechanisms that result in deficient synthesis of gene products, synthesis of defective gene products or disturbed regulation of cellular activities will lead to the development of genetic disorders, secondary to the ensuing pathophysiological alterations of cellular functions.
Maintaining the stability, integrity and species-specific identity of the genome represents a prerequisite, not only for executing cell functions properly, but more fundamentally for the beginning, continuation and conservation of life. It is the preservation of the collaborative and integrated intimate relationship of these three aspects of the genome that represent the real kernel and true essence of existence of all forms of life. Many pathogenetic mechanisms that drastically affect genome stability and genome integrity have been defined. These particular groups of mutations constitute important detrimental events that act via different pathways, e.g. defective genetic repair mechanisms or the premature induction of apoptosis, leading ultimately to the loss of genome stability, integrity and induction of cell death. On molecular or cellular level, these mutations might be considered as life-ending mutations. These mutations might also act in a different way through the total loss of reproductive fitness and the disappearance of individual genomes from the gene pool of certain species [2] .
The spectrum of pathogenetic mechanisms and the resulting pathophysiological disturbances that underlie the development of genetic disorders is quite wide in view of the complexity of the structural organization of the genome and the strict functional specialization that characterizes each of its components. Additionally, the obscure nature and unclear functions of many components of the genetic material, undoubtedly, conceal many, still unknown, pathogenetic mechanisms and hinder proper understanding of their exact pathways. It is hoped that the final completion of the human genome project might disclose the exact and complete structural organization of the human genome. However, a parallel human genome function project aiming at defining the complete functional spectrum of the genome seems to be an indispensable and imperative task in order to finalize the knowledge of our genetic material [3] .
Currently defined pathogenetic mechanisms and pathophysiological alterations implicated in the pathogenesis of genetic disorders include the following: 
Anti-mutation mechanisms of the human genome and human proteome
The human genome develops, persists and works in a hostile environment full of existing, and continuously generated, mutagens. Mutational events induced by external factors, which include physical, chemical and biological mutagens, have widespread detrimental effects on the stability and integrity of the genome as well as on the stability and integrity of the proteome. Additionally, further and considerable damage of the structural organization and functional capabilities of both the genome and the proteome regularly occurs on continuous and progressive basis due to the continuously generated burden of internal mutagens that result from the diverse metabolic activities of the exceedingly large number of metabolic networks of the cell. Unless a powerful and effective protective and repair system actively participates in protecting the genome and proteome of the cell against the deleterious effects of mutations, and in efficient repair of resulting damage, maintaining the stability and integrity of both of these bio-systems that constitute the framework of life activities within the cell would have been impossible [2] . The human genome is endowed with a spectacular multifaceted strong anti-mutation system responsible for maintaining stability and integrity of the genome and preserving its identity. It acts by protecting the genome from the detrimental effects of mutation and by repairing mutation-induced damage. Obviously, the balance between the pathological effects of mutation and the ability of the anti-mutation system to counteract and to reduce the consequences of these effects represents the main factor that determines the likelihood of having a mutation-induced genetic disease. The human antimutation system comprises both innate mechanisms common to, and shared by, all individuals, e.g. degeneracy of the genetic code, and acquired aspects determined by the inherited genetic background of each human being, e.g. DNA repair system [6] .
The human transcriptome, being subjected to the same mutational events that can affect, alter and damage the DNA, seems to have efficient anti-mutation mechanisms to guard against occurrence of errors during RNA transcription and to correct and repair some post-transcription defects of mRNA that can cause errors during protein translation. A separate RNA-proofreading system seems to exist and it probably acts during transcription by relying on the sequence complementarity information or database stored within the complementary silent or non-transcribing strand of DNA. Depending on the sequence of the active strand to ensure accurate transcription might result in improper transcription if mismatch errors occur due to, e.g. polymerase dysfunction. This assumption might, partly, explain the still un-understandable behavior of gene function which involves, seemingly needless, indirect and energy consuming mechanisms by transcribing a complementary mRNA molecule, rather than an identical mRNA, that has to be decoded again by rRNA and tRNA in the ribosome during translation [ 
